Press Release: Sanofi to acquire Vigil Neuroscience, Inc.,

Why did Target's sales drop this quarter? How will Trump's tax bill affect Medicare? What caused the recent S&P 500 decline? Why is Nike raising product prices now? How is OpenAI benefiting from hiring Jony Ive? What impact do Trump tariffs have on retailers? Why are US Treasury yields spiking recently? How did crypto prices reach new record highs? What risks do AI and automation pose to jobs?

Press Release: Sanofi to acquire Vigil Neuroscience, Inc.,

globenewswire.com/news-release/2025/05/21/3086232/0/en/Press-Release-Sanofi-to-acquire-Vigil-Neuroscience-Inc-adding-a-new-investigational-medicine-to-treat-Alzheimer-s-disease-to-the-neurology-pipeline.html

Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
Paris, May 22, 2025. Sanofi announced today that it has entered into an agreement to acquire Vigil Neuroscience, Inc. (“Vigil”), a publicly traded…

This story appeared on globenewswire.com, 2025-05-22 07:04:50.420000.